<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02953431</url>
  </required_header>
  <id_info>
    <org_study_id>16-061</org_study_id>
    <nct_id>NCT02953431</nct_id>
  </id_info>
  <brief_title>Increased Lung Volume as Controller Therapy for Asthma</brief_title>
  <official_title>Increased Lung Volume as Controller Therapy for Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an early phase clinical trial to test the efficacy of elevating lung volume with
      positive expiratory pressure (PEEP) as a controller therapy for asthma in patients with a BMI
      ≥ 35 kg/m2.

      There will be two phases to this trial.

      Phase I:

      In the first phase we will determine the optimal duration of PEEP that is effective as a
      controller therapy in asthma. Up to 9 participants will complete this this phase.

      Phase II:

      The 2nd phase will be a randomized double-blinded controlled trial of PEEP 0 versus PEEP 10
      (using the duration of PEEP determined in phase I) as a controller therapy for asthma. Twenty
      participants will complete this phase.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of 10 versus 0 cmH2O PEEP on airways responsiveness to inhaled methacholine will
      be studied using an adaptive &quot;3+3&quot; phase I/II study design.

      Dose Titration Phase (phase I):

      The efficacy of 8 hours of PEEP on airway responsiveness will be tested in three subjects.

      Efficacy will be defined as a 25% improvement in the impedance response to methacholine in
      all three subjects. If this occurs in all subjects, shorter durations of PEEP will be studied
      (4 hours then one hour).

      Conversely, if &quot;dose escalation&quot; is required, 3 nights, then 7 nights of PEEP will be
      studied.

      Randomized-controlled study phase (phase II):

      Participants will be randomized to PEEP 10 or PEEP 0. The duration of PEEP will be determined
      in the dose titration phase. The effect on response to inhaled methacholine, lung function
      and asthma control will be determined.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 7, 2018</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in impedance of lung measured by forced oscillation</measure>
    <time_frame>Through study completion, an average of one week</time_frame>
    <description>Average change in impedance in response to methacholine in participants assigned to PEEP 0 versus PEEP 10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in spirometric lung function (FEV1 and FVC)</measure>
    <time_frame>Through study completion, an average of one week</time_frame>
    <description>Average change in lung function in response to methacholine in participants assigned to PEEP 0 versus PEEP 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in asthma control</measure>
    <time_frame>Through study completion, an average of one week</time_frame>
    <description>Average change in asthma control in response to methacholine in participants assigned to PEEP 0 versus PEEP 10</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">29</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>PEEP 0</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will be randomized to positive expiratory pressure (PEEP) 0</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEEP 10</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomized to positive expiratory pressure (PEEP) 10</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Positive Expiratory Pressure</intervention_name>
    <description>Positive Expiratory Pressure will be administered through a PEEP valve attached to a mask</description>
    <arm_group_label>PEEP 0</arm_group_label>
    <arm_group_label>PEEP 10</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Physician diagnosis of asthma

          2. PC20 to methacholine &lt; 16 mg/ml

          3. Asthma diagnosis age =&gt; 12 years

          4. IgE &lt; 100 IU/ml

          5. Ages 18-60 years

          6. BMI &gt;=35 kg/m2

        Exclusion Criteria:

          1. Fever of &gt; 38oC in last week

          2. FEV1 &lt; 60 % predicted

          3. Other significant disease that in the opinion of the investigator would interfere with
             study.

          4. Inability to perform required testing.

          5. Smoking within last 6 months.

          6. ≥ 20 pack year smoking history

          7. Inability to provide informed consent

          8. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Dixon, BM BCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Dixon, BM BCh</last_name>
    <phone>802 656 3525</phone>
    <email>anne.dixon@uvm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephanie Burns</last_name>
    <phone>802 847 2103</phone>
    <email>stephanie.burns@uvmhealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vermont Lung Center</name>
      <address>
        <city>Colchester</city>
        <state>Vermont</state>
        <zip>05446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erick Maclean</last_name>
      <email>erick.maclean@uvmhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Bates JH, Dixon AE. Potential role of the airway wall in the asthma of obesity. J Appl Physiol (1985). 2015 Jan 1;118(1):36-41. doi: 10.1152/japplphysiol.00684.2014. Epub 2014 Oct 23.</citation>
    <PMID>25342709</PMID>
  </results_reference>
  <results_reference>
    <citation>Chapman DG, Irvin CG, Kaminsky DA, Forgione PM, Bates JH, Dixon AE. Influence of distinct asthma phenotypes on lung function following weight loss in the obese. Respirology. 2014 Nov;19(8):1170-7. doi: 10.1111/resp.12368. Epub 2014 Aug 19.</citation>
    <PMID>25138203</PMID>
  </results_reference>
  <results_reference>
    <citation>Al-Alwan A, Bates JH, Chapman DG, Kaminsky DA, DeSarno MJ, Irvin CG, Dixon AE. The nonallergic asthma of obesity. A matter of distal lung compliance. Am J Respir Crit Care Med. 2014 Jun 15;189(12):1494-502. doi: 10.1164/rccm.201401-0178OC.</citation>
    <PMID>24821412</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2016</study_first_submitted>
  <study_first_submitted_qc>November 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2016</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Anne Dixon</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Results will be published in the archival literature, and this will include a complete description of experimental and analytical methods used. All original data will be stored and available to interested investigators with appropriate regulatory approvals in place</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

